Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
CorMedix announced that the FDA has accepted for filing a supplemental New Drug Application (sNDA) for REZZAYO (rezafungin for injection) for the prophylaxis of invasive fungal disease. The FDA granted Priority Review for the application, which is supported by positive Phase III ReSPECT study data, and set a PDUFA target action date in Q1 2027.
Strategy Inc announced that its board of directors approved a $1.0 billion increase to its digital credit securities repurchase program, raising the total authorization from $2.0 billion to $3.0 billion. During the week of October 12, 2026, the company also repurchased approximately 1.94 million shares of its STRC preferred stock for $193.1 million and sold $22.0 million of Class A common stock to fund bitcoin purchases.
Super League stockholders approved a strategic investment from Metaplanet, Inc. involving the contribution of 2,100 Bitcoin and $2.5 million in cash. Upon closing, the company will be renamed Superplanet, Inc. and issue 44,859,400 shares of common stock at $3.00 per share, establishing a Bitcoin-based treasury platform.
Value
$135M
Counterparty
Metaplanet Holdings, Inc.
“I’m deeply grateful to our stockholders for their support. Their approval brings us one step closer to redefining what this company can become. If the transaction closes, we would no longer be defined solely by our current scale. Alongside an operating business that continues to serve many of the world’s most recognizable brands, we would have a treasury seeded with 2,100 Bitcoin and the potential to build a significant position over time.”
Matt Edelman, Chairman, Chief Executive Officer and President of Super League
Strive, Inc. provided an operational update disclosing the purchase of 4,045 bitcoin between October 12 and October 16, 2026, bringing its total holdings to 36,818 bitcoin. The company also reported updates to its cash position, share count, and the full exercise or expiration of its outstanding traditional warrants.
Centrus Energy Signs $116M M&A Deal with Westerman Holdings, LLC
Centrus Energy Corp. acquired 100% of Westerman Holdings, LLC, a U.S. equipment manufacturing and engineering firm, for approximately $116 million in a mix of cash and stock. The acquisition brings a key supplier of centrifuge components in-house to secure Centrus' supply chain and diversify its revenue base into non-nuclear industrial sectors. Westerman will operate as a wholly owned subsidiary, and its CEO Jacob Garrett will transition to President of the unit and Vice President of Centrus.
Silgan Holdings Signs $3.4B M&A Deal with Trivium Packaging B.V.
Silgan Holdings announced a transformational deal to combine its Metal Containers and flat cap closures businesses with Trivium Packaging B.V. to create a new $7.3 billion partnership called Silgan Metal Containers and Closures (Silgan MCC). Silgan will retain a 60% controlling interest in the partnership while receiving $2.3 billion in cash proceeds, with the acquisition of Trivium valued at an enterprise value of approximately $3.4 billion.
Value
$3.4B
Counterparty
Trivium Packaging B.V.
“This strategic portfolio acceleration reflects our commitment to value creation through deliberate portfolio construction and strategic capital deployment, enabled by the strength of our businesses and our exceptional teams.”
Adam Greenlee, President and Chief Executive Officer
News Corp provided a daily update on its existing $1 billion stock repurchase program as required by Australian Securities Exchange (ASX) rules. The filing includes specific transaction notifications for the repurchase of Class A and Class B common stock in the open market.
FirstEnergy Pennsylvania Electric $850M Debt Financing
FirstEnergy Pennsylvania Electric Company is extending the expiration date of its exchange offer for $300 million of 4.150% Senior Notes due 2028 and $550 million of 4.550% Senior Notes due 2031. The offer, which swaps unregistered notes for registered versions, has been extended from October 16, 2026, to October 30, 2026, with approximately 99.4% of the notes already tendered.
EquipmentShare.com Inc raised its full-year 2026 financial guidance, increasing its total revenue outlook to a range of $5.81B to $6.05B. The company cited strong customer demand, high fleet utilization, and increasing productivity across its expanding rental network as primary drivers for the improved outlook.
Marker Therapeutics Wins $2.6M Contract from Food & Drug Administration
Marker Therapeutics was awarded a $2.6 million grant from the FDA's Orphan Products Clinical Trials program to advance its lead MAR-T cell therapy, MT-601, for pancreatic cancer. The non-dilutive funding will support a Phase 1 clinical study in patients with locally advanced unresectable pancreatic cancer. Marker was one of only six recipients selected from 66 applications in fiscal year 2026.
Applied Digital CEO; Chairman Wes Cummins Buys $1.01M of Stock
Wes Cummins, CEO; Chairman, bought 55,803 shares of Applied Digital Corp. at $18.04 a share, worth $1.01M in total on Oct 16, 2026. Shares held after the trade: 5,874,453 (+1.0%).
Disc Medicine announced positive topline results from its pivotal Phase 3 APOLLO trial of bitopertin in patients with erythropoietic protoporphyria (EPP). The trial met all primary and secondary endpoints, including a 41.4% reduction in whole-blood PPIX and a significant increase in pain-free light tolerance, with an NDA resubmission planned by the end of 2026.
Term
6 months
“Today represents a potential breakthrough in the science and treatment of EPP. We could not have hoped for a better outcome, and we are grateful to the patients, caregivers, and physicians who have partnered with us throughout the clinical development of bitopertin.”
John Quisel, J.D., Ph.D., President and Chief Executive Officer
“These results are compelling evidence of the clinical benefit of a mechanism aimed at reducing the production of PPIX, the fundamental cause of disease. It has been an incredible journey from establishing the original hypothesis of targeting heme synthesis in cellular models to seeing that biology translate into the clear and meaningful clinical effects from APOLLO.”
Applied Digital President Jason Gechen Zhang Buys $5.66M of Stock
Jason Gechen Zhang, President, bought 300,000 shares of Applied Digital Corp. at $18.86 a share, worth $5.66M in total on Oct 16, 2026. Shares held after the trade: 2,839,227 (+11.8%).
EyePoint announced topline results from LUCIA, its second pivotal Phase 3 clinical trial of DURAVYU for wet age-related macular degeneration (wet AMD). The trial failed to meet its primary endpoint of statistical non-inferiority in mean change in best corrected visual acuity (BCVA) compared to the aflibercept control, although it did meet secondary endpoints related to treatment burden reduction and safety.
Nebius Group Insider John Wilson Boynton IV Sells $1.29M of Stock
John Wilson Boynton IV sold 7,260 shares of Nebius Group N.V. at $164.80 to $188.77 a share (average $177.63) in 19 transactions, worth $1.29M in total on Oct 15, 2026. Shares held after the trade: 403,522 (-0.0%).
CBIZ reported third-quarter 2026 revenue of $702 million and net income of $47 million, representing a 56.7% increase in net income year-over-year. The company also provided an update on its pending $5.0 billion acquisition by Grant Thornton and New Mountain Capital, which is expected to close in Q4 2026. Due to the pending transaction, the company has suspended its full-year guidance and earnings conference calls.
Rekor Systems filed a verified complaint in the Delaware Court of Chancery against former director Viraj Mehta, alleging a breach of his fiduciary duty of loyalty. The lawsuit relates to the company's December 2025 financing with a hedge fund and seeks compensatory damages, restitution of director compensation, and disgorgement.
Counterparty
Viraj Mehta
“Our Board took this action after months of careful investigation. Directors have a fundamental obligation to provide complete and candid information when critical financing decisions are being made. We believe the facts warrant judicial review, and we intend to pursue the Company's claims and every appropriate remedy available to protect Rekor and its shareholders.”
Robert A. Berman, Chairman and Chief Executive Officer
“This is a first step, not the end of our review. We continue to examine unusually high stock-borrow utilization rates, other unusual activity in Rekor common stock, and relevant financing and ownership matters. We will follow the evidence wherever it leads. Access to capital should not come at the expense of market integrity, corporate governance or the rights of public shareholders.”
Robert A. Berman, Chairman and Chief Executive Officer
Cellebrite DI CFO David Barter Sells $136K of Stock
David Barter, CFO, sold 12,134 shares of Cellebrite DI Ltd. at $11.21 a share, worth $136K in total on Oct 16, 2026. Shares held after the trade: 322,085 (-3.6%).
Cleveland-Cliffs reported third-quarter 2026 revenues of $5.6 billion and GAAP net income of $165 million, exceeding its previous Adjusted EBITDA guidance. The company highlighted strong performance from its Stelco acquisition and improved average selling prices, while announcing the indefinite idling of Stelco's galvanizing lines due to Canadian market oversupply. Management expects further EBITDA growth in Q4 and significant debt reduction to reach a leverage target of under 2.5x by mid-2027.
Term
Q3 2026
“Third quarter was our strongest quarter in three years, with adjusted EBITDA of $612 million, a number above the $575 million guidance we provided three months ago. Average selling price, sales volumes, and unit costs all moved in the right direction relative to Q2 performance.”
Lourenco Goncalves, Cliffs’ Chairman and CEO
“Based on the new contracts we have already signed with our clients and prevailing index price forecasts, we would expect our 2027 adjusted EBITDA to exceed $4 billion.”
Jefferies Financial Group Inc. filed a formal investor presentation deck as Exhibit 99.1 for its 2026 Investor Meeting held on October 19, 2026. The presentation includes a strategic overview from CEO Rich Handler and President Brian Friedman, along with divisional reviews of investment banking, equities, fixed income, and asset management.
Sunshine Silver Mining & Refining provided an operational update on its Sunshine Mine in Idaho, highlighting progress on underground development, infrastructure upgrades, and site preparation. The company is advancing toward a feasibility study in Q2 2027 and a planned return to production in late 2028, with current work including the modernization of the Jewell and Silver Summit shafts.
Barnwell Industries M&A Deal with local Canadian corporation
Barnwell Industries provided a status update and Q&A regarding its previously announced agreement to sell its Canadian oil and natural gas business for C$9 million. The consideration includes C$4 million in cash and a 5% gross overriding royalty valued at C$5 million, which the buyer has an option to repurchase for C$5 million in the future.
Fifth Third Bancorp reported Q3 2026 financial results, highlighting the successful systems conversion and integration of Comerica. The company achieved a reported EPS of $0.90 and an adjusted EPS of $1.13, driven by a 3% sequential increase in net interest income and strong deposit growth in Southeast and Southwest markets.
Term
Q3 2026
“Fifth Third's third quarter reflected the earnings power of the combined company. Even while integrating Comerica, our adjusted return on tangible common equity and efficiency ratio improved from the second quarter, and credit performance remained stable.”
Tim Spence, Fifth Third Chairman, CEO and President
“We live in a more volatile world, and competition for deposits is heating up. Multiple sources of low-cost deposits and limited exposure to the borrowers most sensitive to higher rates give us flexibility regardless of the rate environment. We are building a Fifth Third that is better and not just bigger.”
Tim Spence, Fifth Third Chairman, CEO and President
Enhanced Group Inc. announced a one-for-ten reverse stock split of its Class A and Class B common stock, effective October 29, 2026. The split is intended to consolidate every ten shares into one share to adjust the trading price on the NYSE, with no fractional shares being issued. The action follows a definitive information statement filed earlier in the month and complies with NYSE advance notice requirements.
Transocean Wins $550M Contract from undisclosed operator
Transocean Ltd. secured two ultra-deepwater drillship contracts in the U.S. Gulf of Mexico totaling approximately $550 million in firm backlog. The Deepwater Proteus was awarded a 700-day, ten-well campaign valued at $325 million, while the Deepwater Conqueror received a 450-day, five-well award valued at $225 million.
reAlpha Tech Corp. filed an amendment to its previous 8-K to provide updated audited financial statements for InstaMortgage Inc., which it acquired on August 19, 2026. This filing specifically corrects an inadvertent reference to government auditing standards in the auditor's report and provides the necessary financial exhibits required for the completed merger.
Elite Pharmaceuticals Insider Barry H. Dash Buys $26K of Stock
Barry H. Dash bought 100,000 shares of Elite Pharmaceuticals Inc at $0.2598 a share, worth $26K in total on Oct 9, 2026. Shares held after the trade: 3,365,555 (+3.1%).
OpenWorld, Inc. has entered into a definitive merger agreement to acquire Blocksight Holdings Co., an AI agent developer for real-world asset tokenization. The acquisition will be settled via the issuance of 641,924 shares of OpenWorld common stock, representing 4% of the company's post-merger fully diluted capitalization. Blocksight's AI agents will be integrated into the OpenWorld Enterprise platform to automate deal structuring and reporting for over $1.1 billion in recently announced tokenized financing programs.
Yanjun Wang, CCO and GC, sold 1,946 shares of Sea Ltd at $94.12 to $97.62 a share (average $96.08) in 7 transactions, worth $187K in total between Oct 15, 2026 and Oct 16, 2026. Shares held after the trade: 77,834 (-0.2%).
Tamboran Resources appointed its current CEO, Todd Abbott, to the additional role of Managing Director and as a Class II director on the Board. The appointment formalizes his executive leadership at the board level as the company transitions from the appraisal phase to the development of its Beetaloo Basin assets. Mr. Abbott will not receive additional compensation for his service as a director.